source
- Merck-Moderna cancer vaccine win spurs stock jump, speculation of Keytruda-like impactAs the dust settles on phase 3 data that added $45 billion to Moderna’s market cap, analysts have begun to ask a question that could define cancer care in the coming years: Can use of the vaccine b…Fierce Biotech · 10h ago↗ source
- Meet Aletta: The first FDA approved robotic blood draw deviceThe FDA has approved Vitestro’s Aletta as the first standalone robotic device in the U.S. designed to draw blood without the need for hands-on human help.Fierce Biotech · 11h ago↗ source
- FDA approves Regeneron’s garetosmab for ultra-rare bone-forming diseaseThe FDA has granted approval to Regeneron's antibody garetosmab, which targets activin A, for the treatment of fibrodysplasia ossificans progressiva (FOP). FOP is an ultra‑rare disorder that causes…